Specialty Pharmacy

Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.

Scientists utilized nanotechnology to improve HIV treatments.

Even macrophages aren’t safe from HIV.

Top articles of the week from Specialty Pharmacy Times.

Recombinant shell nanoparticles could deliver drugs straight to cancer cells.

Sarcopenia identified as an independent risk factor.

African American patients are more likely to be diagnosed with advanced cancer and have higher mortality.

Top news of the day from across the health care landscape.

The United States is in desperate need of an overhaul to the current health care system.

Drug may offer an effective alternative to chemotherapy for patients with leukemia.

Combination treatment helped increase invasive disease-free survival in patients with an aggressive type of early breast cancer.

Newly-discovered microbial products shown to impact a protein used in certain cancer treatments.

Analysis confirms the safety and efficacy of palliative radiation therapy for painful bone metastases.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.

Top news of the day from across the health care landscape.

Study finds syringe services outreach should be more focused on whites, who now make up a large portion of injection drug users.

Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Carcinoid syndrome affects some patients with carcinoid tumors.

Investigational drug treats patients with relapsed or refractory AML with an isocitrate dehydrogenase 2 mutation.

Top news of the day from across the health care landscape.

Combination therapy shows promise treating pancreatic cancer.

Investigational MS drug lowers the relapse rate during a phase 3 clinical trial.

G-CSF promotes regeneration of sperm cells in cancer patients.

A majority of glioblastomas change their genomic profile during therapy, new research finds.

Targeting the interactions between neurons and cancer cells may be a powerful strategy in future cancer treatments.

Fixed-dose combination provides another oral treatment option for patients with diabetes.